Healthy Skepticism Library item: 12029
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Kessel M, Frank F.
A better prescription for drug-development financing.
Nat Biotechnol 2007 Aug; 25:(8):859-66
http://www.nature.com/nbt/journal/v25/n8/abs/nbt0807-859.html;jsessionid=EBDED800FEBD7E8BD221E527F96656FB
Abstract:
As the cost of drug development continues to rise and public markets shift their attention to companies with late-stage products, an increasing diversity of financing options are becoming available to biotech companies with early-stage clinical programs.
e-mail: mark@symphonycapital.com
Keywords:
Publication Types:
Review
MeSH Terms:
Capital Financing/organization & administration*
Drug Design*
Drug Industry/organization & administration*
Investments/organization & administration*
Models, Organizational*
Pharmaceutical Preparations/economics*
Research/organization & administration*
United States
Substances:
Pharmaceutical Preparations
